Physician profile
Matthew Ryan Haack
NPI 1811186828
$3,788.95
in general payments reported to CMS, 2019-2025
34 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $341 · 2021: $232 · 2022: $580 · 2023: $316 · 2024: $731 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.22 |
| Education | $122.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $725.53 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Electromed, INC. | $527.13 | 2019-2025 | Smartvest |
| Grifols USA, LLC | $388.79 | 2019-2024 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $278.20 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Genzyme Corporation | $224.90 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $204.04 | 2024-2025 | Opsumit, Uptravi |
| Intuitive Surgical, INC. | $173.29 | 2022 | |
| Jazz Pharmaceuticals INC. | $148.58 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.41 | 2019-2025 | Ofev |
| Philips North America LLC | $120.41 | 2019-2022 | |
| Mylan Specialty L.P. | $95.97 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $78.11 | 2019 | |
| Baxter Healthcare | $63.17 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $58.56 | 2025 | Yupelri |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $52.70 | 2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $43.97 | 2024-2025 | Dupixent |
| Insmed, INC. | $43.21 | 2022-2024 | Arikayce |
| Pfizer INC. | $41.54 | 2022-2025 | |
| Verona Pharma, INC. | $36.52 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $34.98 | 2024 | Winrevair |
| Amgen INC. | $33.49 | 2025 | Tezspire |
| United Therapeutics Corporation | $25.74 | 2021-2023 | Tyvaso |
| Tactile Systems Technology INC | $24.62 | 2024 | Entre Plus, Flexitouch Plus |
| Axsome Therapeutics, INC. | $23.41 | 2025 | Sunosi |
| Advanced Respiratory, INC | $22.07 | 2019 | |
| Idorsia Pharmaceuticals US INC | $20.83 | 2023 | Quviviq |
| Lilly USA, LLC | $16.92 | 2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $16.81 | 2020 | |
| Genentech USA, INC. | $16.11 | 2019 | |
| Resmed Corp | $15.38 | 2024 | |
| Galvanize Therapeutics, INC | $15.15 | 2024 | Aliya System |
| Gilead Sciences, INC. | $13.85 | 2021 | |
| Pulmonx Corporation | $13.08 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Haack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.